Valneva SE ADR

Yahoo Finance • 9 months ago

Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript

Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript March 20, 2024 Valneva SE misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $0.2. VALN isn't one of the 30 most popular stocks among hedge funds at the... Full story

Yahoo Finance • 12 months ago

16 Most Promising Long-Term Stocks According to Analysts

In this piece, we will take a look at the 16 most promising long-term stocks according to analysts. If you want to skip our overview of long term investing, then you can take a look at 5 Most Promising Long-Term Stocks According to Analyst... Full story

Yahoo Finance • last year

Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript

Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Good day and thank you for standing by. Welcome to the Valneva 9 Months 2023 Financial Results Call. [Operator Instructions]. I would now like to hand th... Full story

Yahoo Finance • 2 years ago

Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate

Pfizer Inc (NYSE: PFE) and Valneva SE (NASDAQ: VALN) announce that Pfizer, as the study sponsor, will discontinue a significant percentage of participants in the U.S. who had been enrolled in the VALOR Phase 3 study of a Lyme disease vacci... Full story

Yahoo Finance • 2 years ago

10 Best Healthcare Stocks For the Long Term

In this article, we will take a look at the 10 best healthcare stocks for the long term. You can skip this part and go to 5 Best Healthcare Stocks For the Long Term. The healthcare sector is one of those rare, evergreen areas of the indus... Full story

Yahoo Finance • 2 years ago

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences

VALNEVA Saint-Herblain (France), October 10, 2022 – ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today it will present on its single-shot chikungunya vaccine candidate at several leading scientific... Full story

Yahoo Finance • 2 years ago

VALNEVA - Declaration of shares and voting rights - June 30, 2022

VALNEVA VALNEVA Declaration of shares and voting rights June 30, 2022 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Sain... Full story

Yahoo Finance • 3 years ago

Valneva announces resumption of trading of its ordinary shares on Euronext Paris

VALNEVA Saint-Herblain(France), June 23,2022 – ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces the resumption of trading of its ordinary shares on the regulated market of Euronext in Paris, starting a... Full story

Yahoo Finance • 3 years ago

Valneva Nearly Doubles After Pfizer Invests $95 Million For A Hefty Stake

Valneva stock rocketed Tuesday on a $95 million investment from Pfizer, its Lyme disease vaccine partner. Pfizer will get an 8.1% stake.... Full story

Yahoo Finance • 3 years ago

Pfizer makes equity investment in Valneva as they prepare for Phase 3 trial of Lyme disease vaccine candidate

U.S.-listed shares of Valneva soared 81.9% in premarket trading on Tuesday, the day after Pfizer Inc. announced a $95 million equity investment in Valneva as part of a previously established agreement aimed at developing a Lyme disease vac... Full story

Yahoo Finance • 3 years ago

VALNEVA Declaration of shares and voting rights - April 30, 2022

VALNEVA VALNEVA Declaration of shares and voting rights April 30, 2022 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Sai... Full story